Non-dispense Comfort Comparison of Two Silicone Hydrogel Lenses

The purpose of this study is to compare subjective responses to two contact lenses after 15 minutes of wear.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myopia Eye Diseases Refractive Errors

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Currently wearing soft contact lenses
Replaces lenses on a weekly or longer schedule
Other protocol-defined inclusion/exclusion criteria may apply

Exclusion criteria

Requires concurrent ocular medication
Eye injury or surgery within twelve weeks immediately prior to enrollment
Currently wearing soft toric lens wearers
Those who dispose of their soft lenses on a daily basis
Other protocol-defined inclusion/exclusion criteria may apply

Treatment and study plan

Lotrafilcon A contact lens

Device

Investigational, silicone hydrogel, spherical, soft contact lens

Senofilcon A contact lens

Device

Commercially marketed, silicone hydrogel, spherical, soft contact lens

Primary outcomes

Comfort After Insertion

Time frame: 30-60 seconds after initial insertion

Evaluated by the subject and measured on a 10-point scale, with 1 being poor and 10 being excellent.

Sponsors and collaborators

Lead sponsor

CIBA VISION

Industry

Registry information

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Dec 16, 2008
Registry last updated: Jun 29, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed